Zhejiang, CHN
Junfang(June) Xu, Chief Medical Officer, Global Development Center of Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Dr Xu was a trained physician in internal medicine and clinical pharmacology, with more than 5 years medical practice and 17+ years pharmaceutical industry experience in translational medicine and clinical development from Novartis, Merck, Sanofi and Alphamab Oncology etc.
In 2021, Dr Xu was appointed as Chief Medical Officer, Global Development Center of Huadong Medicine, started establishing clinical development departments of Huadong Medicine, and advanced more than 50+ fast growing innovative portfolio in oncology, immunology, metabolic disease and live biotherapeutic products. Dr Xu successfully supported and drived more than 18+ NDA/BLA submissions/approvals.
Clinical Validation of a Transdermal GFR Measurement System in Chinese Individuals
Tuesday, March 24, 2026
10:00 AM - 11:00 AM Central Time
Disclosure(s): Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.: Employee (any industry) (Ongoing)
Bioequivalence and Efficacy Study of MB-102 With Transdermal GFR Measurement in Chinese Subjects
Tuesday, March 24, 2026
10:00 AM - 11:00 AM Central Time
Disclosure(s): Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.: Employee (any industry) (Ongoing)
